Search Results 751-760 of 17904 for monoclonal antibody

1. Amyloidosis Clinical Trials - Mayo Clinic Research

   ... antibody-drug conjugate (ADC) for the treatment of relapsed or ... Monoclonal antibodies, such as isatuximab, may interfere with the ability of ...

2. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

   Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Bevacizumab blocks the ability of tumors to grow new blood vessels and ...

3. Precision diagnosis of MOG antibody-associated disease is critical for timely, targeted therapy - Mayo Clinic

   Mayo Clinic offers the first coordinated, multidisciplinary clinic in the world that is devoted specifically to MOGAD, a rare antibody-mediated inflammatory ...

4. Sarcoma Clinical Trials

   Monoclonal antibodies, such as ganitumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as ...

5. Vinorelbine Tartrate and Cyclophosphamide in Combination with Bevacizumab or Temsirolimus in Treating Patients with Recurrent or Refractory Rhabdomyosarcoma - Mayo Clinic

   Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. ... 3 half-lives (or 6 weeks) must have elapsed since previous monoclonal ...

6. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

7. Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

   RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer ...

8. Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

9. Bispecific antibody therapy: T-cell engagement - Mayo Clinic

   Some bispecific antibody therapies link immune T cells directly to cancer cells. One arm of the bispecific attaches to a T cell. The other arm attaches to ...

10. Monoclonal Gammopathy Of Undetermined Significance Clinical Trials - Mayo Clinic Research

    This study is being done to see if daratumumab is safe and effective in the treatment of proliferative glomerulonephritis with monoclonal immune deposits ( ...